Intercept’s travails continue as it pulls NASH drug filing in EUAlready scrambling to refile its obeticholic acid (OCA) drug for non-alcoholic steatohepatitis (NASH) after the FDA rejected it Share XIntercept’s travails continue as it pulls NASH drug filing in EUhttps://pharmaphorum.com/news/intercepts-travails-continue-as-it-pulls-nash-drug-filing-in-eu/
Digital health firm ChronWell raises $6m for liver disease toolkitUS remote healthcare specialist ChronWell has raised $6 million from investors that will be used to accelerate the Share XDigital health firm ChronWell raises $6m for liver disease toolkithttps://pharmaphorum.com/news/digital-health-firm-chronwell-raises-6m-for-liver-disease-toolkit/
Trial sets up filings for uniQure’s haemophilia gene therapyDutch biotech uniQure and partner CSL Behring are planning to file for approval of their gene therapy for Share XTrial sets up filings for uniQure’s haemophilia gene therapyhttps://pharmaphorum.com/news/trial-sets-up-filings-for-uniqures-haemophilia-gene-therapy/
Consumer health innovation – where passion and science meetHeather Barnes, external innovation lead EMEA at Johnson and Johnson Consumer Health, is a scientist who is truly Share XConsumer health innovation – where passion and science meethttps://pharmaphorum.com/sales-marketing/consumer-health-innovation-jnj/
Seizing opportunities with perfectly pitched messagesPersonal relationships have been the dominant force in sales for generations but the pandemic has ripped up this Share XSeizing opportunities with perfectly pitched messageshttps://pharmaphorum.com/sales-marketing/seizing-opportunities-with-perfectly-pitched-messages/
Frontiers Health Digital Innovators: Debiopharm Innovation Fund S.A.’s Tanja Dowepharmaphorum’s founder, Dr Paul Tunnah, talks with Debiopharm Innovation Fund’s CEO Tanja Dowe at Frontiers Health as part Share XFrontiers Health Digital Innovators: Debiopharm Innovation Fund S.A.’s Tanja Dowehttps://pharmaphorum.com/digital/frontiers-health-digital-innovators-debiopharm-tanja-dowe/
How the combination treatment challenge impacts patients and how we are working together to solve itHow the combination treatment challenge impacts patients Access to medicines attracts a great deal of interest from patients, Share XHow the combination treatment challenge impacts patients and how we are working together to solve ithttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/takeda-combination-challenge-impacts-patients/
Recruiting patients to increase diversity & inclusion in clinical trials: one size does not fit allMore so now than ever, the inclusion of more diverse, and often more relevant, study populations is gathering Share XRecruiting patients to increase diversity & inclusion in clinical trials: one size does not fit allhttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/recruiting-patients-to-increase-diversity-inclusion-in-clinical-trials-one-size-does-not-fit-all/
The booming life sciences sector needs dynamic real estate supportBruntwood SciTech is the UK’s leading property provider dedicated to driving the growth of the science and technology Share XThe booming life sciences sector needs dynamic real estate supporthttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/the-booming-life-sciences-sector-needs-dynamic-real-estate-support/
Oncology treatment decisions aren’t just based on clinical data Share XOncology treatment decisions aren’t just based on clinical datahttps://pharmaphorum.com/webinars/oncology-treatment-decisions-arent-just-based-on-clinical-data/
The power of R&D collaborations to improve outcomes in rare diseases Share XThe power of R&D collaborations to improve outcomes in rare diseaseshttps://pharmaphorum.com/webinars/pharma-research-outcomes-rare-diseases/
Using AI to make a big impact for emerging and mid-sized biopharma companies Share XUsing AI to make a big impact for emerging and mid-sized biopharma companieshttps://pharmaphorum.com/webinars/using-ai-to-make-a-big-impact-for-emerging-and-mid-sized-biopharma-companies/
Sales coaching: preparing for the new reality in pharmaCOVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an Share XSales coaching: preparing for the new reality in pharmahttps://pharmaphorum.com/whitepapers/pharma-sales-coaching-new-reality/
Utilising content metrics to improve digital engagementPharma companies are producing and distributing more digital content than ever due to the pandemic, meaning the content Share XUtilising content metrics to improve digital engagementhttps://pharmaphorum.com/whitepapers/content-metrics-digital-engagement-veeva/
Transform patient experience with intelligent hyper-personalisationSince 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and Share XTransform patient experience with intelligent hyper-personalisationhttps://pharmaphorum.com/whitepapers/patient-experience-personalisation-indegene/
Frontiers Health Digital Innovators: Orion Pharma’s Sammeli Liikkanen Share XFrontiers Health Digital Innovators: Orion Pharma’s Sammeli Liikkanenhttps://pharmaphorum.com/digital/digital-innovators-orion-pharma-sammeli-likkanen/
Frontiers Health Digital Innovators: Debiopharm Innovation Fund S.A.’s Tanja Dowe Share XFrontiers Health Digital Innovators: Debiopharm Innovation Fund S.A.’s Tanja Dowehttps://pharmaphorum.com/digital/frontiers-health-digital-innovators-debiopharm-tanja-dowe/
Frontiers Health Digital Innovators: Boston Scientific EMEA’s Rodamni Peppa Share XFrontiers Health Digital Innovators: Boston Scientific EMEA’s Rodamni Peppahttps://pharmaphorum.com/digital/frontiers-health-digital-innovators-boston-scientific-emeas-rodamni-peppa/
Identifying Rising Stars Share XIdentifying Rising Starshttps://pharmaphorum.com/partner-content/identifying-rising-stars/
Social Health: What it is and why it matters for pharma Share XSocial Health: What it is and why it matters for pharmahttps://pharmaphorum.com/partner-content/social-health-what-it-is-and-why-it-matters-for-pharma/
How Label Management Solutions Can Help CDMOS Grow Their In-House Capabilities Share XHow Label Management Solutions Can Help CDMOS Grow Their In-House Capabilitieshttps://pharmaphorum.com/partner-content/how-label-management-solutions-can-help-cdmos-grow-their-in-house-capabilities/
Poor Glycaemic Control and Tooth Loss Study Share XPoor Glycaemic Control and Tooth Loss Studyhttps://pharmaphorum.com/partner-content/largest-tooth-loss-research-study-results/
AXON appoints Colette Balaam as its new US Managing Partner Share XAXON appoints Colette Balaam as its new US Managing Partnerhttps://pharmaphorum.com/partner-content/axon-appoints-colette-balaam-as-its-new-us-managing-partner/
Prescient Healthcare Group to Partner with Bridgepoint Development Capital Share XPrescient Healthcare Group to Partner with Bridgepoint Development Capitalhttps://pharmaphorum.com/partner-content/prescient-healthcare-group-to-partner-with-bridgepoint-development-capital/
